Clinical trial

Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to…

NCT00006349 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00006349
Title Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer
Official title An Exploratory Trial of Donepezil and Vitamin E to Prevent Cognitive Dysfunction in Patients With Small Cell Lung Cancer (SCLC) After Cancer Treatment Which Includes Prophylatic Cranial Irradiation (PCI)
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cognitive/Functional Effects, Delirium, Depression, Lung Cancer, Radiation Toxicity
Intervention type Dietary Supplement, Drug, Other
Interventions vitamin E, donepezil hydrochloride, placebo
Enrollment 9
Start date Feb 1, 2001
Primary completion Jan 1, 2005
Completion Jan 1, 2007
First posted May 29, 2003
Last update posted Jul 13, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies